Prevention and reversal of myocardial failure in endotoxin shock.
D000818:Animals; D001285:Atropine / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D004077:Digoxin / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D004926:Escherichia coli; D006333:Heart Failure / Q000188:drug therapy* / Q000517:prevention & control; D006339:Heart Rate / Q000187:drug effects; D009203:Myocardial Infarction / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D012772:Shock, Septic / Q000150:complications*; D014655:Vascular Resistance / Q000187:drug effects
D002245:Carbon Dioxide; D004077:Digoxin; D001285:Atropine